Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Merck & Co
(NY:
MRK
)
117.46
+0.06 (+0.05%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Merck & Co
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
71
72
Next >
3 Dividend Stocks to Buy for a Recession-Proof Portfolio
April 15, 2023
Many investors believe we’re at the point of no return, leading us to look at some of the best dividend stocks for a recession.
Via
InvestorPlace
10 Best Performing Blue Chip Stocks
April 14, 2023
While there may be varying interpretations among investors, the term “blue chip” typically denotes companies that are regarded as leaders in their respective fields.
Via
Talk Markets
MRK: Chart Of The Week
April 13, 2023
The 20-day moving average is coming in at about 170 – 172, which is 6 above where the current price level is.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2023
April 13, 2023
Via
Benzinga
Check Out What Whales Are Doing With MRK
April 12, 2023
Via
Benzinga
Where Merck & Co Stands With Analysts
April 10, 2023
Via
Benzinga
AMZN Stock Alert: 12 Takeaways From the 2023 Amazon Shareholder Letter
April 13, 2023
Amazon (AMZN) stock is a hot topic among traders on Thursday after CEO Andy Jassy released his annual shareholder letter.
Via
InvestorPlace
Why Is Merck (MRK) Stock Up Today?
April 13, 2023
Merck (MRK) stock is on the move Thursday after the pharmaceutical company got an update from the FDA concerning Keytruda.
Via
InvestorPlace
Apple To Rally Around 18%? Here Are 10 Other Analyst Forecasts For Thursday
April 13, 2023
Credit Suisse boosted the price target for Apple Inc. (NASDAQ: AAPL) from $184 to $188. Credit Suisse analyst Shannon Cross maintained an Outperform rating. Apple shares fell 0.4% to close at $160.10...
Via
Benzinga
Analysts At H.C. Wainwright & Co. Set 12-Month Target Of $15 Per Share For ENLV Thanks To High Profile Collaboration Agreement, Multiple Ongoing Clinical Trials
April 13, 2023
This month, H.C. Wainwright & Co.
Via
Benzinga
US Stocks Could Flatline As Rate-Hike Doubts Linger: Analyst Sees Market Strength In April Back-Half
April 13, 2023
Trading in the index futures suggests a cautious opening on Thursday as traders put inflation fears on the back burner and look ahead to the first-quarter earnings season.
Via
Benzinga
This Is What Whales Are Betting On Merck & Co
April 06, 2023
Via
Benzinga
Here's How Much You Would Have Made Owning Merck & Co Stock In The Last 5 Years
April 04, 2023
Via
Benzinga
These 3 Health Care Stocks Delivering High-Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts
April 12, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
2 Forever Stocks to Buy No Matter What the Market Is Doing
April 11, 2023
These two top stocks are trading at very reasonable prices right now.
Via
The Motley Fool
Joe Biden Plans On Running For Re-Election In 2024, Apple Clocks Highest Decline In Q1 PC Shipments, Fox News Confidential Defamation Lawsuit Settlement: Today's Top Stories
April 10, 2023
Benzinga Biden's 2024 Ambition: President Announces Intent to Pursue Second Term
Via
Benzinga
Moderna Surges On A Key Win For Its Merck-Partnered Cancer Vaccine In Europe
April 10, 2023
Moderna shares are flirting with their key moving averages on a win in Europe.
Via
Investor's Business Daily
Can You Still Buy the Dow Jones' Best-Performing April Stocks?
April 10, 2023
Each is benefiting from recent good news, but there's also a theme-based tailwind brewing that could last a while.
Via
The Motley Fool
2 Ultra-Cheap Dividend Stocks to Buy in April
April 04, 2023
These two big pharma stocks are trading at steep discounts.
Via
The Motley Fool
Merck, Eisai Shelve Keytruda Plus Lenvima Combo Trial In Skin Cancer Setting, Disappoints In Certain Type Of Colorectal Cancer
April 10, 2023
Via
Benzinga
Week In Review: Suzhou Duality Out-Licenses Two ADCs To BioNTech In $1.7 Billion Deal
April 08, 2023
Duality Biologics out-licensed global rights (ex-China) for two ADC candidates to BioNTech, Pfizer’s partner, for one of the two original COVID-19 vaccines in a deal worth $170 million upfront and up...
Via
Talk Markets
5 S&P 500 Stocks Showing Strength As Recession Fears Rise
April 07, 2023
Medical stocks are holding up amid economic and market uncertainty.
Via
Investor's Business Daily
5 Recession-Proof Stocks With High Cash, Low Debt, Strong Dividends To Protect Your Portfolio In 2023
April 07, 2023
Markets are increasingly concerned about an impending recession following the latest U.S. economic data, which showed a slowing in the pace of growth in the labor market and service sector activity in...
Via
Benzinga
What To Expect When Merus Presents Petosemtamab Data Update At AACR
April 06, 2023
Via
Benzinga
Novo Nordisk Seeks to Solidify Its Lead in Diabetes Treatment and Crushing the Market
April 06, 2023
Its market dominance in diabetes drugs that also help with weight loss is set to continue for at least the next few years.
Via
The Motley Fool
GILD - Chart Of The Week
April 05, 2023
The daily chart looks pretty strong right now. The stock is trying to break through the resistance line that started around the beginning of December.
Via
Talk Markets
AstraZeneca' Cancer Drug Combo Meets Goal In Late-Stage Ovarian Cancer Study
April 05, 2023
Via
Benzinga
Russia Warns As Finland Joins NATO, Spotify Highlights Struggle With Live Audio, Anticompetitive Charges Against Activision Blizzard: Today's Top Stories
April 04, 2023
Benzinga Finland Joins NATO Doubling Border Length, Russia Issues Warning
Via
Benzinga
3 Top Healthcare Stocks to Buy for April
April 04, 2023
These pharmaceutical companies' shares are down, but their prospects are rising.
Via
The Motley Fool
FDA Approves Merck's Keytruda Combined With Seagen/Astellas's Padcev For Advanced Urothelial Cancer
April 04, 2023
Via
Benzinga
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
71
72
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.